142 related articles for article (PubMed ID: 26918600)
1. Germline genetic variations in PDZD2 and ITPR2 genes are associated with clear cell renal cell carcinoma in Chinese population.
Zhang N; Wu Y; Gong J; Li K; Lin X; Chen H; Yu Y; Gou Y; Hou J; Jiang D; Na R; Wang X; Ding Q; Xu J
Oncotarget; 2017 Apr; 8(15):24196-24201. PubMed ID: 26918600
[TBL] [Abstract][Full Text] [Related]
2. Germline genetic variations at 11q13 and 12p11 locus modulate age at onset for renal cell carcinoma.
Audenet F; Cancel-Tassin G; Bigot P; Audouin M; Gaffory C; Ondet V; Thibault F; Auribault K; Gazut S; Benhabiles N; Azzouzi AR; Méjean A; Rouprêt M; Cussenot O
J Urol; 2014 Feb; 191(2):487-92. PubMed ID: 23911636
[TBL] [Abstract][Full Text] [Related]
3. One-carbon metabolism pathway gene variants and risk of clear cell renal cell carcinoma in a Chinese population.
Zhang L; Meng X; Ju X; Cai H; Li P; Cao Q; Shao P; Qin C; Yin C
PLoS One; 2013; 8(11):e81129. PubMed ID: 24278388
[TBL] [Abstract][Full Text] [Related]
4. XRCC3 Thr241Met and XPD Lys751Gln gene polymorphisms and risk of clear cell renal cell carcinoma.
Loghin A; Bănescu C; Nechifor-Boila A; Chibelean C; Orsolya M; Nechifor-Boila A; Tripon F; Voidazan S; Borda A
Cancer Biomark; 2016; 16(2):211-7. PubMed ID: 26682510
[TBL] [Abstract][Full Text] [Related]
5. A genome-wide association study identifies a novel susceptibility locus for renal cell carcinoma on 12p11.23.
Wu X; Scelo G; Purdue MP; Rothman N; Johansson M; Ye Y; Wang Z; Zelenika D; Moore LE; Wood CG; Prokhortchouk E; Gaborieau V; Jacobs KB; Chow WH; Toro JR; Zaridze D; Lin J; Lubinski J; Trubicka J; Szeszenia-Dabrowska N; Lissowska J; Rudnai P; Fabianova E; Mates D; Jinga V; Bencko V; Slamova A; Holcatova I; Navratilova M; Janout V; Boffetta P; Colt JS; Davis FG; Schwartz KL; Banks RE; Selby PJ; Harnden P; Berg CD; Hsing AW; Grubb RL; Boeing H; Vineis P; Clavel-Chapelon F; Palli D; Tumino R; Krogh V; Panico S; Duell EJ; Quirós JR; Sanchez MJ; Navarro C; Ardanaz E; Dorronsoro M; Khaw KT; Allen NE; Bueno-de-Mesquita HB; Peeters PH; Trichopoulos D; Linseisen J; Ljungberg B; Overvad K; Tjønneland A; Romieu I; Riboli E; Stevens VL; Thun MJ; Diver WR; Gapstur SM; Pharoah PD; Easton DF; Albanes D; Virtamo J; Vatten L; Hveem K; Fletcher T; Koppova K; Cussenot O; Cancel-Tassin G; Benhamou S; Hildebrandt MA; Pu X; Foglio M; Lechner D; Hutchinson A; Yeager M; Fraumeni JF; Lathrop M; Skryabin KG; McKay JD; Gu J; Brennan P; Chanock SJ
Hum Mol Genet; 2012 Jan; 21(2):456-62. PubMed ID: 22010048
[TBL] [Abstract][Full Text] [Related]
6. Genetic scores based on risk-associated single nucleotide polymorphisms (SNPs) can reveal inherited risk of renal cell carcinoma.
Wu Y; Zhang N; Li K; Chen H; Lin X; Yu Y; Gou Y; Hou J; Jiang D; Na R; Wang X; Ding Q; Xu J
Oncotarget; 2016 Apr; 7(14):18631-7. PubMed ID: 27229762
[TBL] [Abstract][Full Text] [Related]
7. A genome-wide association study of renal cell carcinoma among African Americans.
Purdue MP; Ye Y; Wang Z; Colt JS; Schwartz KL; Davis FG; Rothman N; Chow WH; Wu X; Chanock SJ
Cancer Epidemiol Biomarkers Prev; 2014 Jan; 23(1):209-14. PubMed ID: 24220910
[TBL] [Abstract][Full Text] [Related]
8. Von Hippel-Lindau (VHL) inactivation in sporadic clear cell renal cancer: associations with germline VHL polymorphisms and etiologic risk factors.
Moore LE; Nickerson ML; Brennan P; Toro JR; Jaeger E; Rinsky J; Han SS; Zaridze D; Matveev V; Janout V; Kollarova H; Bencko V; Navratilova M; Szeszenia-Dabrowska N; Mates D; Schmidt LS; Lenz P; Karami S; Linehan WM; Merino M; Chanock S; Boffetta P; Chow WH; Waldman FM; Rothman N
PLoS Genet; 2011 Oct; 7(10):e1002312. PubMed ID: 22022277
[TBL] [Abstract][Full Text] [Related]
9. Polymorphism rs4787951 in IL-4R contributes to the increased risk of renal cell carcinoma in a Chinese population.
Lin Y; Yuan Q; Qian F; Qin C; Cao Q; Wang M; Chu H; Zhang Z
Gene; 2019 Feb; 685():242-247. PubMed ID: 30472377
[TBL] [Abstract][Full Text] [Related]
10. Germline genetic variants in somatically significantly mutated genes in tumors are associated with renal cell carcinoma risk and outcome.
Shu X; Gu J; Huang M; Tannir NM; Matin SF; Karam JA; Wood CG; Wu X; Ye Y
Carcinogenesis; 2018 May; 39(6):752-757. PubMed ID: 29635281
[TBL] [Abstract][Full Text] [Related]
11. Association between ACYP2 polymorphisms and the risk of renal cell cancer.
Wang Y; Zhang Y; Sun Y; Wu J; Chang J; Xiong Z; Niu F; Gu S; Jin T
Mol Genet Genomic Med; 2019 Nov; 7(11):e966. PubMed ID: 31487124
[TBL] [Abstract][Full Text] [Related]
12. Gene-environment interaction of genome-wide association study-identified susceptibility loci and meat-cooking mutagens in the etiology of renal cell carcinoma.
Melkonian SC; Daniel CR; Ye Y; Tannir NM; Karam JA; Matin SF; Wood CG; Wu X
Cancer; 2016 Jan; 122(1):108-15. PubMed ID: 26551148
[TBL] [Abstract][Full Text] [Related]
13. Combined effects of DNA methyltransferase 1 and 3A polymorphisms and urinary total arsenic levels on the risk for clear cell renal cell carcinoma.
Yang SM; Huang CY; Shiue HS; Pu YS; Hsieh YH; Chen WJ; Lin YC; Hsueh YM
Toxicol Appl Pharmacol; 2016 Aug; 305():103-110. PubMed ID: 27292127
[TBL] [Abstract][Full Text] [Related]
14. Genetic Variants in Caveolin-1 and RhoA/ROCK1 Are Associated with Clear Cell Renal Cell Carcinoma Risk in a Chinese Population.
Zhao R; Liu K; Huang Z; Wang J; Pan Y; Huang Y; Deng X; Liu J; Qin C; Cheng G; Hua L; Li J; Yin C
PLoS One; 2015; 10(6):e0128771. PubMed ID: 26066055
[TBL] [Abstract][Full Text] [Related]
15. Joint association of genome-wide association study-identified susceptibility loci and dietary patterns in risk of renal cell carcinoma among non-Hispanic whites.
Melkonian SC; Daniel CR; Hildebrandt MA; Tannir NM; Ye Y; Chow WH; Wood CG; Wu X
Am J Epidemiol; 2014 Sep; 180(5):499-507. PubMed ID: 25053674
[TBL] [Abstract][Full Text] [Related]
16. Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma.
Machiela MJ; Hofmann JN; Carreras-Torres R; Brown KM; Johansson M; Wang Z; Foll M; Li P; Rothman N; Savage SA; Gaborieau V; McKay JD; Ye Y; Henrion M; Bruinsma F; Jordan S; Severi G; Hveem K; Vatten LJ; Fletcher T; Koppova K; Larsson SC; Wolk A; Banks RE; Selby PJ; Easton DF; Pharoah P; Andreotti G; Freeman LEB; Koutros S; Albanes D; Mannisto S; Weinstein S; Clark PE; Edwards TE; Lipworth L; Gapstur SM; Stevens VL; Carol H; Freedman ML; Pomerantz MM; Cho E; Kraft P; Preston MA; Wilson KM; Gaziano JM; Sesso HS; Black A; Freedman ND; Huang WY; Anema JG; Kahnoski RJ; Lane BR; Noyes SL; Petillo D; Colli LM; Sampson JN; Besse C; Blanche H; Boland A; Burdette L; Prokhortchouk E; Skryabin KG; Yeager M; Mijuskovic M; Ognjanovic M; Foretova L; Holcatova I; Janout V; Mates D; Mukeriya A; Rascu S; Zaridze D; Bencko V; Cybulski C; Fabianova E; Jinga V; Lissowska J; Lubinski J; Navratilova M; Rudnai P; Szeszenia-Dabrowska N; Benhamou S; Cancel-Tassin G; Cussenot O; Bueno-de-Mesquita HB; Canzian F; Duell EJ; Ljungberg B; Sitaram RT; Peters U; White E; Anderson GL; Johnson L; Luo J; Buring J; Lee IM; Chow WH; Moore LE; Wood C; Eisen T; Larkin J; Choueiri TK; Lathrop GM; Teh BT; Deleuze JF; Wu X; Houlston RS; Brennan P; Chanock SJ; Scelo G; Purdue MP
Eur Urol; 2017 Nov; 72(5):747-754. PubMed ID: 28797570
[TBL] [Abstract][Full Text] [Related]
17. CTLA-4 and CD28 genes' polymorphisms and renal cell carcinoma susceptibility in the Polish population--a prospective study.
Tupikowski K; Partyka A; Kolodziej A; Dembowski J; Debinski P; Halon A; Zdrojowy R; Frydecka I; Karabon L
Tissue Antigens; 2015 Nov; 86(5):353-61. PubMed ID: 26403483
[TBL] [Abstract][Full Text] [Related]
18. GNAS1 (Gαs) gene T393C polymorphism and renal cell carcinoma risk in a North Indian population: a case-control study.
Arjumand W; Ahmad ST; Nafees S; Ali N; Rashid S; Seth A; Sultana S
Genet Test Mol Biomarkers; 2012 Sep; 16(9):1062-6. PubMed ID: 22931242
[TBL] [Abstract][Full Text] [Related]
19. Methylenetetrahydrofolate reductase (MTHFR) gene C677T, A1298C and G1793A polymorphisms: association with risk for clear cell renal cell carcinoma and tumour behaviour in men.
Safarinejad MR; Shafiei N; Safarinejad S
Clin Oncol (R Coll Radiol); 2012 May; 24(4):269-81. PubMed ID: 21489764
[TBL] [Abstract][Full Text] [Related]
20. CD146 Promoter Polymorphism (rs3923594) Is Associated with Recurrence of Clear Cell Renal Cell Carcinoma in Chinese Population.
Feng G; Huang HB; Ye XB; Zhang P; Huang JJ; Huang LZ; Cheng L; Pu C; Li G
Dis Markers; 2017; 2017():2543059. PubMed ID: 28626293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
